Dorzolamide hydrochloride and timolol maleate ophthalmic solution has a market value of roughly $80 million for the 12 months ended December 2020, according to IQVIA.
Beth Zelnick Kaufman is joining Akorn as executive vice president, chief legal officer and corporate secretary while Sandhya Goyal is assuming the role of senior vice president and chief scientific officer.